Skip to main content
. Author manuscript; available in PMC: 2013 Sep 24.
Published in final edited form as: Pediatr Blood Cancer. 2009 Dec;53(6):1140–1142. doi: 10.1002/pbc.22139

Table I.

BRCA2 mutations and outcomes in children with posterior fossa tumors

ID Cancer (age, years) Nucleotide change I Nucleotide change II Outcome Reference
1 Brain Tumor (3) 7691/insAT 9900/insA Not documented 4
2 Posterior fossa tumor-
radiologic findings
consistent with
medulloblastoma or
astrocytoma (4.9)
6174delT 9435T→A Dead 6
3 Astrocytoma (2) 6174delT 9435T→A Dead 6
4 Medulloblastoma (4.5) 6174delT 886delGT Not documented 6
5 Medulloblastoma (2.5) 5301insA 7690T→C Not documented 6
6 Medulloblastoma (3.5) 4150G→T 9424C→T Not documented 6
7 Medulloblastoma (2.3) 886delGT 8447T→A Not documented 5
8 Medulloblastoma (4.3) 886delGT 8447T→A Dead 5
9 Medulloblastom (6) 886delTG 5873C→A Dead * relapse of
medulloblastoma
at 12 y
7
10 Posterior fossa tumor
(1)
-VATER associated
anamolies
1548del4 1548del4 Dead 10
11 Medulloblastoma (3.1)
- VATER associated
anomalies
6174delT 9424C→T Not documented 3
12 Medulloblastoma (1.7) 6174delT 886delGT Alive without
evidence of disease
Current report
13 Medulloblastoma (2) 3492insT IVS19+3A→G Dead Personal
communication